Dr Louis McMahon has joined RSSL Pharma as pharmaceutical consultant. He will liaise between RSSL Pharma's scientists and their customers, particularly in a troubleshooting role, helping customers to understand the implication of analytical results and to respond as necessary.
McMahon previously held senior positions at Novartis, Biovail, Wyeth and Pfizer. He is a European registered toxicologist, and was formerly an analytical development manager and forensic lead at Pfizer Newbridge, where he helped establish the company's site analytical development and industrial forensic capabilities.
